Form 4 for SRPT Sarepta Therapeutics, Inc.

Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-10 · accession 0000950170-25-037527 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-03-11	2025-03-10	SRPT	Rothfuss Cristin	EVP, GC	F - Tax	$100.13	-491	12.8K	-4%	-$49.2K
D	2025-03-11	2025-03-10	SRPT	Rothfuss Cristin	EVP, GC	A - Grant	—	+8,276	21.1K	+64%	—
D	2025-03-11	2025-03-10	SRPT	Rothfuss Cristin	EVP, GC	A - Grant	$0.00	+16.6K	16.6K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-03-10	F	D	491	$100.13	12,834	D	—	—	(F1) Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022.
2	Common	Common Stock	2025-03-10	A	A	8,276	—	21,110	D	—	—	(F2) The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
3	Derivative	Stock Options (right to buy)	2025-03-10	A	A	16,644	$0.00	16,644	D	$99.69 · 2026-03-10 to 2035-03-10	16,644 Common Stock	(F3) Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.